View Older Stories View More Recent Stories
-
CONVENING NOTICE - ANNUAL GENERAL MEETING IN IMMUNOVIA AB (publ)
-
Levy Konigsberg Files Motion to Consolidate 22 Talc Mesothelioma Lawsuits for Trial Against Johnson & Johnson
-
AHF Confronts Cigna CEO over PBM’s ‘Rapacious’ Greed
-
Committee Representing Talc-Related Cancer Victims Files Motion to Dismiss
-
J&J aims for up to $43 billion valuation for consumer health unit Kenvue
-
Cleveland-Cliffs Reports First-Quarter 2023 Results
-
The Brattle Group Welcomes Bankruptcy & Restructuring Expert David Lorry as Senior Consultant
-
Open Source M.D Announces a New Paradigm to Improve Quality Health Care and Financial Standing for Hospitals
-
Cancer victims urge US judge to dismiss J&J talc unit second bankruptcy
-
McKool Smith Secures $303 Million Verdict in Patent Infringement Case Against Samsung
-
ICONIX ANNOUNCES THE EXPIRATION AND RESULTS OF ITS CASH TENDER OFFER FOR ITS CLASS A-2 NOTES
-
Structurlam Has Entered into a US$60 Million Stalking Horse Asset Purchase Agreement
-
Analysts see these stocks benefiting from Bed Bath & Beyond (BBBY) bankruptcy
-
MACCO Restructuring Group wins Sale of the Year awarded by the American Bankruptcy Institute for the successful sale of the La Muralla IV, a purpose-built semi-submersible drilling rig
-
Garrett Motion Reports First Quarter 2023 Financial Results
-
Garrett Motion Reports First Quarter 2023 Financial Results
-
Nasdaq underperforms on worries about tech earnings ahead
-
Bed Bath Bankruptcy (BBBY) could be a modest tailwind to Wayfair (W) Overstock (OSTK) revenues - BofA
-
German business sentiment improves slightly in April
-
Bed Bath & Beyond shares plunge 25% as retailer goes bankrupt
-
Bed Bath & Beyond (BBBY) files chapter 11 bankruptcy
-
Bed Bath & Beyond's rocky ride to bankruptcy filing
-
Bed Bath & Beyond files for bankruptcy protection after long struggle, begins liquidation sale
-
Bed Bath & Beyond Inc. Files Voluntary Chapter 11 Petitions
-
Brazil's Oi postpones release of 2022 financial statements
-
Bed Bath & Beyond considers asset sales, Sixth Street bankruptcy loan - Bloomberg News
-
Veji Announces Proposed Share Issuance under its BIA Proposal
-
SVB CEO, CFO resign, co appoints turnaround expert as interim finance head
-
Park National Corporation reports financial results for first quarter 2023
-
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement
-
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN MAHA ENERGY AB (PUBL)
-
FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value
-
FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value
-
This Week in Consumer News: 15 Stories You Need to See
-
Debt.com Turns 10 and Celebrates by Teaching Financial Literacy to Students
-
The Week in Press Releases: 12 Stories You Need to See
-
Advanced Reinsurance Contracts and Disputes Masterclass Training Course (London, United Kingdom - June 13, 2023)
-
HMN Financial, Inc. Announces First Quarter Results
-
U.S. judge denies bail to exiled Chinese businessman Guo Wengui in fraud case
-
First Trust Intermediate Duration Preferred & Income Fund Declares its Monthly Common Share Distribution of $0.1075 Per Share for May
-
Ventas Announces Pricing of its Tender Offers for 2.80% Senior Notes Due 2024 and 4.125% Senior Notes Due 2024
-
Hilco Corporate Finance Expands Its Special Situation and Restructuring Investment Banking Services with the Addition of Senior Managing Director, Richard S. Klein
-
$100M in Medical Debt Eliminated thanks to Philanthropic Gift
-
US judge halts most talc lawsuits against J&J, stops trials
-
2022 Earnings Report
-
Oceania Cruises Marks 20th Anniversary and the Launch of New Ship, Vista, with an Exclusive 20-Year-Old Small-Batch Cask of Whisky from Chapter 7
-
Brazil's government takes measures to boost consumer and capital market credit
-
BRG Appoints Mark Renzi as Leader of Financial Services Industry Practice
-
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies
-
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies

